世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Pharmaceutical Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Testing was estimated to be worth US$ 6838 million in 2024 and is forecast to a readjusted size of US$ 9895 million by 2031 with a CAGR of 5.5% during the forec... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Pharmaceutical Testing was estimated to be worth US$ 6838 million in 2024 and is forecast to a readjusted size of US$ 9895 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.There are many testing items for pharmaceutical testing, including drug quality testing, drug ingredient testing, drug heavy metal testing, drug adverse reaction testing, drug sealing testing, biological drug testing, drug appearance testing, drug routine testing, drug physical and chemical testing, drug safety testing and drug defect testing, etc. The purpose of pharmaceutical testing is to prevent substandard drugs from entering the market and ensure the safety of drugs. China Pharmaceutical Testing core manufacturers are WuXi AppTec、CTI、Weipu、PONY Medicine、SGS、WuXi Biologics and etc, the top five manufacturers account for about 14% of the Chinese share. Wuxi AppTec has the largest market, with a presence in more than 30 countries worldwide.. In terms of product type, Drug Packaging Material Testing is the largest segment with a share of about 27%. And in terms of application, Finished Drugs and Environment is the largest downstream segment with a share of 38%. This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Testing by region & country, by Type, and by Application. The Pharmaceutical Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Testing. Market Segmentation By Company Eurofins WuXi AppTec Pace Analytical Services Catalent LabCorp (Covance) PPD Element (Exova) ALS Pharmaceutical Intertek Group SGS Boston Analytical DYNALABS CTI Weipu PONY Medicine WuXi Biologics Standard Group ICAS APTBIO Saifu Lab GBTc Kerbio Assure NIFDC Frontage Pharmaron Segment by Type Raw Material Testing Microbiological Testing Drug Packaging Material Testing Macromolecule Drug Biological Analysis and Testing GMP Public System and Equipment Validation Testing Pharmacovigilance Other Segment by Application CRO CMO and CDMO Finished Drugs and Environment By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Pharmaceutical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Revenue of Pharmaceutical Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Revenue of Pharmaceutical Testing in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Pharmaceutical Testing Product Introduction 1.2 Global Pharmaceutical Testing Market Size Forecast (2020-2031) 1.3 Pharmaceutical Testing Market Trends & Drivers 1.3.1 Pharmaceutical Testing Industry Trends 1.3.2 Pharmaceutical Testing Market Drivers & Opportunity 1.3.3 Pharmaceutical Testing Market Challenges 1.3.4 Pharmaceutical Testing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Pharmaceutical Testing Players Revenue Ranking (2024) 2.2 Global Pharmaceutical Testing Revenue by Company (2020-2025) 2.3 Key Companies Pharmaceutical Testing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Pharmaceutical Testing Product Offered 2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Testing 2.6 Pharmaceutical Testing Market Competitive Analysis 2.6.1 Pharmaceutical Testing Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Testing Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Testing as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Raw Material Testing 3.1.2 Microbiological Testing 3.1.3 Drug Packaging Material Testing 3.1.4 Macromolecule Drug Biological Analysis and Testing 3.1.5 GMP Public System and Equipment Validation Testing 3.1.6 Pharmacovigilance 3.1.7 Other 3.2 Global Pharmaceutical Testing Sales Value by Type 3.2.1 Global Pharmaceutical Testing Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Pharmaceutical Testing Sales Value, by Type (2020-2031) 3.2.3 Global Pharmaceutical Testing Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 CRO 4.1.2 CMO and CDMO 4.1.3 Finished Drugs and Environment 4.2 Global Pharmaceutical Testing Sales Value by Application 4.2.1 Global Pharmaceutical Testing Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Pharmaceutical Testing Sales Value, by Application (2020-2031) 4.2.3 Global Pharmaceutical Testing Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Pharmaceutical Testing Sales Value by Region 5.1.1 Global Pharmaceutical Testing Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Pharmaceutical Testing Sales Value by Region (2020-2025) 5.1.3 Global Pharmaceutical Testing Sales Value by Region (2026-2031) 5.1.4 Global Pharmaceutical Testing Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Pharmaceutical Testing Sales Value, 2020-2031 5.2.2 North America Pharmaceutical Testing Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Pharmaceutical Testing Sales Value, 2020-2031 5.3.2 Europe Pharmaceutical Testing Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Pharmaceutical Testing Sales Value, 2020-2031 5.4.2 Asia Pacific Pharmaceutical Testing Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Pharmaceutical Testing Sales Value, 2020-2031 5.5.2 South America Pharmaceutical Testing Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Pharmaceutical Testing Sales Value, 2020-2031 5.6.2 Middle East & Africa Pharmaceutical Testing Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Pharmaceutical Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Pharmaceutical Testing Sales Value, 2020-2031 6.3 United States 6.3.1 United States Pharmaceutical Testing Sales Value, 2020-2031 6.3.2 United States Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Pharmaceutical Testing Sales Value, 2020-2031 6.4.2 Europe Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Pharmaceutical Testing Sales Value, 2020-2031 6.5.2 China Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.5.3 China Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Pharmaceutical Testing Sales Value, 2020-2031 6.6.2 Japan Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Pharmaceutical Testing Sales Value, 2020-2031 6.7.2 South Korea Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Pharmaceutical Testing Sales Value, 2020-2031 6.8.2 Southeast Asia Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Pharmaceutical Testing Sales Value, 2020-2031 6.9.2 India Pharmaceutical Testing Sales Value by Type (%), 2024 VS 2031 6.9.3 India Pharmaceutical Testing Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Eurofins 7.1.1 Eurofins Profile 7.1.2 Eurofins Main Business 7.1.3 Eurofins Pharmaceutical Testing Products, Services and Solutions 7.1.4 Eurofins Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.1.5 Eurofins Recent Developments 7.2 WuXi AppTec 7.2.1 WuXi AppTec Profile 7.2.2 WuXi AppTec Main Business 7.2.3 WuXi AppTec Pharmaceutical Testing Products, Services and Solutions 7.2.4 WuXi AppTec Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.2.5 WuXi AppTec Recent Developments 7.3 Pace Analytical Services 7.3.1 Pace Analytical Services Profile 7.3.2 Pace Analytical Services Main Business 7.3.3 Pace Analytical Services Pharmaceutical Testing Products, Services and Solutions 7.3.4 Pace Analytical Services Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.3.5 Pace Analytical Services Recent Developments 7.4 Catalent 7.4.1 Catalent Profile 7.4.2 Catalent Main Business 7.4.3 Catalent Pharmaceutical Testing Products, Services and Solutions 7.4.4 Catalent Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.4.5 Catalent Recent Developments 7.5 LabCorp (Covance) 7.5.1 LabCorp (Covance) Profile 7.5.2 LabCorp (Covance) Main Business 7.5.3 LabCorp (Covance) Pharmaceutical Testing Products, Services and Solutions 7.5.4 LabCorp (Covance) Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.5.5 LabCorp (Covance) Recent Developments 7.6 PPD 7.6.1 PPD Profile 7.6.2 PPD Main Business 7.6.3 PPD Pharmaceutical Testing Products, Services and Solutions 7.6.4 PPD Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.6.5 PPD Recent Developments 7.7 Element (Exova) 7.7.1 Element (Exova) Profile 7.7.2 Element (Exova) Main Business 7.7.3 Element (Exova) Pharmaceutical Testing Products, Services and Solutions 7.7.4 Element (Exova) Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.7.5 Element (Exova) Recent Developments 7.8 ALS Pharmaceutical 7.8.1 ALS Pharmaceutical Profile 7.8.2 ALS Pharmaceutical Main Business 7.8.3 ALS Pharmaceutical Pharmaceutical Testing Products, Services and Solutions 7.8.4 ALS Pharmaceutical Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.8.5 ALS Pharmaceutical Recent Developments 7.9 Intertek Group 7.9.1 Intertek Group Profile 7.9.2 Intertek Group Main Business 7.9.3 Intertek Group Pharmaceutical Testing Products, Services and Solutions 7.9.4 Intertek Group Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.9.5 Intertek Group Recent Developments 7.10 SGS 7.10.1 SGS Profile 7.10.2 SGS Main Business 7.10.3 SGS Pharmaceutical Testing Products, Services and Solutions 7.10.4 SGS Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.10.5 SGS Recent Developments 7.11 Boston Analytical 7.11.1 Boston Analytical Profile 7.11.2 Boston Analytical Main Business 7.11.3 Boston Analytical Pharmaceutical Testing Products, Services and Solutions 7.11.4 Boston Analytical Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.11.5 Boston Analytical Recent Developments 7.12 DYNALABS 7.12.1 DYNALABS Profile 7.12.2 DYNALABS Main Business 7.12.3 DYNALABS Pharmaceutical Testing Products, Services and Solutions 7.12.4 DYNALABS Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.12.5 DYNALABS Recent Developments 7.13 CTI 7.13.1 CTI Profile 7.13.2 CTI Main Business 7.13.3 CTI Pharmaceutical Testing Products, Services and Solutions 7.13.4 CTI Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.13.5 CTI Recent Developments 7.14 Weipu 7.14.1 Weipu Profile 7.14.2 Weipu Main Business 7.14.3 Weipu Pharmaceutical Testing Products, Services and Solutions 7.14.4 Weipu Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.14.5 Weipu Recent Developments 7.15 PONY Medicine 7.15.1 PONY Medicine Profile 7.15.2 PONY Medicine Main Business 7.15.3 PONY Medicine Pharmaceutical Testing Products, Services and Solutions 7.15.4 PONY Medicine Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.15.5 PONY Medicine Recent Developments 7.16 WuXi Biologics 7.16.1 WuXi Biologics Profile 7.16.2 WuXi Biologics Main Business 7.16.3 WuXi Biologics Pharmaceutical Testing Products, Services and Solutions 7.16.4 WuXi Biologics Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.16.5 WuXi Biologics Recent Developments 7.17 Standard Group 7.17.1 Standard Group Profile 7.17.2 Standard Group Main Business 7.17.3 Standard Group Pharmaceutical Testing Products, Services and Solutions 7.17.4 Standard Group Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.17.5 Standard Group Recent Developments 7.18 ICAS 7.18.1 ICAS Profile 7.18.2 ICAS Main Business 7.18.3 ICAS Pharmaceutical Testing Products, Services and Solutions 7.18.4 ICAS Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.18.5 ICAS Recent Developments 7.19 APTBIO 7.19.1 APTBIO Profile 7.19.2 APTBIO Main Business 7.19.3 APTBIO Pharmaceutical Testing Products, Services and Solutions 7.19.4 APTBIO Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.19.5 APTBIO Recent Developments 7.20 Saifu Lab 7.20.1 Saifu Lab Profile 7.20.2 Saifu Lab Main Business 7.20.3 Saifu Lab Pharmaceutical Testing Products, Services and Solutions 7.20.4 Saifu Lab Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.20.5 Saifu Lab Recent Developments 7.21 GBTc 7.21.1 GBTc Profile 7.21.2 GBTc Main Business 7.21.3 GBTc Pharmaceutical Testing Products, Services and Solutions 7.21.4 GBTc Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.21.5 GBTc Recent Developments 7.22 Kerbio 7.22.1 Kerbio Profile 7.22.2 Kerbio Main Business 7.22.3 Kerbio Pharmaceutical Testing Products, Services and Solutions 7.22.4 Kerbio Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.22.5 Kerbio Recent Developments 7.23 Assure 7.23.1 Assure Profile 7.23.2 Assure Main Business 7.23.3 Assure Pharmaceutical Testing Products, Services and Solutions 7.23.4 Assure Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.23.5 Assure Recent Developments 7.24 NIFDC 7.24.1 NIFDC Profile 7.24.2 NIFDC Main Business 7.24.3 NIFDC Pharmaceutical Testing Products, Services and Solutions 7.24.4 NIFDC Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.24.5 NIFDC Recent Developments 7.25 Frontage 7.25.1 Frontage Profile 7.25.2 Frontage Main Business 7.25.3 Frontage Pharmaceutical Testing Products, Services and Solutions 7.25.4 Frontage Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.25.5 Frontage Recent Developments 7.26 Pharmaron 7.26.1 Pharmaron Profile 7.26.2 Pharmaron Main Business 7.26.3 Pharmaron Pharmaceutical Testing Products, Services and Solutions 7.26.4 Pharmaron Pharmaceutical Testing Revenue (US$ Million) & (2020-2025) 7.26.5 Pharmaron Recent Developments 8 Industry Chain Analysis 8.1 Pharmaceutical Testing Industrial Chain 8.2 Pharmaceutical Testing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Pharmaceutical Testing Sales Model 8.5.2 Sales Channel 8.5.3 Pharmaceutical Testing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
